QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
one-third of one redeemable warrant to acquire one Class A ordinary share |
||||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
Emerging growth company |
TB SA ACQUISITION CORP
Form10-Q
For the Period Ended September 30, 2022
Table of Contents
Page | ||||||
PART I. FINANCIAL INFORMATION | ||||||
Item 1. | 1 | |||||
Condensed Balance Sheets as of September 30, 2022 (Unaudited) and December 31, 2021 |
1 | |||||
2 | ||||||
3 | ||||||
4 | ||||||
5 | ||||||
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
22 | ||||
Item 3. | 28 | |||||
Item 4. | 28 | |||||
PART II. OTHER INFORMATION | ||||||
Item 1. | 31 | |||||
Item 1A. | 31 | |||||
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities |
31 | ||||
Item 3. | 31 | |||||
Item 4. | 31 | |||||
Item 5. | 31 | |||||
Item 6. | 32 |
September 30, 2022 (Unaudited) |
December 31, 2021 |
|||||||
Assets |
||||||||
Current assets: |
||||||||
Cash |
$ | $ | ||||||
Prepaid expenses |
||||||||
|
|
|
|
|||||
Total current assets |
||||||||
Marketable securities held in Trust account |
||||||||
Prepaid expenses, non-current |
||||||||
|
|
|
|
|||||
Total assets |
$ |
$ |
||||||
|
|
|
|
|||||
Liabilities and Shareholders’ Equity |
||||||||
Current liabilities: |
||||||||
Accounts payable and accrued expenses |
$ | $ | ||||||
Due to related party |
||||||||
|
|
|
|
|||||
Total current liabilities |
||||||||
Convertible note - related party |
||||||||
Warrant liabilities |
||||||||
|
|
|
|
|||||
Total liabilities |
||||||||
|
|
|
|
|||||
Commitments and Contingencies (See Note 6) |
||||||||
Class A ordinary shares subject to possible redemption, |
||||||||
Shareholders’ Equity (Deficit): |
||||||||
Preference shares, $ |
||||||||
Class A ordinary shares, $ |
||||||||
Class B ordinary shares, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total Shareholders’ Deficit |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Total Liabilities and Shareholders’ Deficit |
$ |
$ |
||||||
|
|
|
|
For the three months ended September 30, 2022 |
For the three months ended September 30, 2021 |
For the nine months ended September 30, 2022 |
For the period from January 27, 2021 (Inception) through September 30, 2021 |
|||||||||||||
Formation and operating costs |
$ | $ | $ | $ | ||||||||||||
Stock compensation expense |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss from operations |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||
Other Income |
||||||||||||||||
Interest earned on marketable securities held in Trust Account |
||||||||||||||||
Offering expenses related to warrant issuance |
( |
) | ||||||||||||||
Change in fair value of working capital loan—related party |
||||||||||||||||
Change in fair value of over-allotment liability |
||||||||||||||||
Change in fair value of warrant liabilities |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total other income, net |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income |
$ |
$ |
$ |
$ |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted average shares outstanding of Class A ordinary share |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net income per share, Class A ordinary share |
$ |
$ |
$ |
$ |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted average shares outstanding of Class B ordinary share |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net income per share, Class B ordinary share |
$ |
$ |
$ |
$ |
||||||||||||
|
|
|
|
|
|
|
|
Ordinary Shares |
Additional Paid-In Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
|||||||||||||||||||||||||
Class A |
Class B |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance as of January 1, 2022 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
Remeasurement of Class A ordinary shares to redemption value |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
Proceeds received in excess of initial fair value of working capital loan—related party |
— | — | — | — | — | |||||||||||||||||||||||
Fair value of Founder Shares transferred to Directors |
— | — | — | — | — | |||||||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Balance as of March 31, 2022 |
( |
) |
( |
) | ||||||||||||||||||||||||
Remeasurement of Class A ordinary shares to redemption value |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
Proceeds received in excess of initial fair value of working capital loan - related party |
— | — | — | — | — | |||||||||||||||||||||||
Fair value of Founder Shares transferred to Directors |
— | — | — | — | — | |||||||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Balance as of June 30, 2022 |
( |
) |
( |
) | ||||||||||||||||||||||||
Fair value of Founder Shares transferred to Directors |
— | — | — | — | — | |||||||||||||||||||||||
Remeasurement of Class A ordinary shares to redemption value |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Balance as of September 30, 2022 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
Ordinary Shares |
Additional Paid-In Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
|||||||||||||||||||||||||
Class A |
Class B |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance as of January 27, 2021 (Inception) |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||
Issuance of Founder Shares |
— | — | — | |||||||||||||||||||||||||
Excess Sponsor paid over Fair value of Private Placement Warrants |
— | — | — | — | — | |||||||||||||||||||||||
Remeasurement of Class A ordinary shares to redemption value |
— | — | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
Fair value of Founder Shares transferred to Directors |
— | — | — | — | — | |||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
Balance as of March 31, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
Forfeiture of Founder Shares |
— | — | ( |
) | ( |
) | — | — | ||||||||||||||||||||
Remeasurement of Class A ordinary shares to redemption value |
— | — | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Balance as of June 30, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
Remeasurement of Class A ordinary shares to redemption value |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Balance as of September 30, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
For the nine months ended September 30, 2022 |
For the period from January 27, 2021 (Inception) Through September 30, 2021 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net income |
$ | $ | ||||||
Adjustments to reconcile net income to net cash used in operating activities: |
||||||||
Offering costs allocated to Warrants |
||||||||
Change in fair value of warrant liabilities |
( |
) | ( |
) | ||||
Change in fair value of working capital loan—related party |
( |
) | ||||||
Change in fair value of over-allotment liabilities |
( |
) | ||||||
Stock compensation expense |
||||||||
Interest earned on marketable securities held in Trust Account |
( |
) | ( |
) | ||||
Changes in current assets and current liabilities: |
||||||||
Prepaid assets |
( |
) | ||||||
Accounts payable and accrued expenses |
||||||||
Due to related party |
||||||||
|
|
|
|
|||||
Net cash used in operating activities |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Cash Flows from Investing Activity: |
||||||||
Investment of cash into Trust Account |
( |
) | ||||||
|
|
|
|
|||||
Net cash provided by (used in) investing activity |
( |
) | ||||||
|
|
|
|
|||||
Cash Flows from Financing Activities: |
||||||||
Proceeds from Initial Public Offering, net of underwriter’s discount |
||||||||
Proceeds from purchase of Private Placement Warrants by related party |
||||||||
Proceeds from issuance of Working Capital Loan—related party |
||||||||
Proceeds from issuance of Promissory note—related party |
||||||||
Payments of Promissory note—related party |
( |
) | ||||||
Proceeds from issuance of Founder Shares |
||||||||
Payment of offering costs |
( |
) | ||||||
|
|
|
|
|||||
Net cash provided by financing activities |
||||||||
|
|
|
|
|||||
Net Change in Cash |
( |
) |
||||||
Cash—Beginning |
||||||||
|
|
|
|
|||||
Cash—Ending |
$ |
$ |
||||||
|
|
|
|
|||||
Supplemental Disclosure of Non-Cash Financing Activity: |
||||||||
Proceeds received in excess of initial fair value of working capital loan—related party |
$ | $ | |
|||||
|
|
|
|
|||||
Remeasurement of Class A ordinary shares subject to possible redemption |
$ | $ | ||||||
|
|
|
|
For the three months ended September 30, 2022 |
For the three months ended September 30, 2021 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Basic and diluted net income per share: |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income |
$ | $ | $ | $ | ||||||||||||
Denominator: |
||||||||||||||||
Weighted-average shares outstanding |
||||||||||||||||
Basic and diluted net income per share |
$ | $ | $ | $ | ||||||||||||
For the nine months ended September 30, 2022 |
For the period from January 27, 2021 (inception) through September 30, 2021 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Basic and diluted net income per share: |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income |
$ | $ | $ | $ | ||||||||||||
Denominator: |
||||||||||||||||
Weighted-average shares outstanding |
||||||||||||||||
Basic and diluted net income per share |
$ | $ | $ | $ | ||||||||||||
Gross proceeds from IPO |
$ | |||
Less: |
||||
Proceeds allocated to Public Warrants |
( |
) | ||
Proceeds allocated to derivative liability |
( |
) | ||
Class A ordinary share issuance costs |
( |
) | ||
Plus: |
||||
Remeasurement adjustment of carrying value to redemption value |
||||
Class A ordinary shares subject to possible redemption at December 31, 2021 |
||||
Plus: |
||||
Remeasurement adjustment of carrying value to redemption value |
||||
Class A ordinary shares subject to possible redemption at September 30, 2022 |
$ |
|||
• | in whole and not in part; |
• | at a price of $ |
• | upon a minimum of |
• | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $ |
• | in whole and not in part; |
• | at $ |
• | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $ |
Number of Shares |
||||
Granted on March 12, 2021 |
||||
Forfeited |
||||
Vested |
( |
) | ||
Unvested Outstanding at December 31, 2021 |
||||
Vested |
( |
) | ||
Unvested Outstanding at September 30, 2022 |
||||
Amount Vested |
||||
Amount vested on March 22, 2021, the Company’s IPO date (represents |
$ | |||
Amount vested on March 22, 2022, one year from the Company’s IPO date (represents |
||||
Amount to be vested upon the Company’s consummation of a successful business combination (represents |
||||
Total vesting amount |
$ |
|||
Number of Shares |
||||
Granted on June 30, 2022 |
||||
Forfeited |
||||
Vested |
( |
) | ||
Unvested Outstanding at September 30, 2022 |
||||
Amount Vested |
||||
Amount vested retrospectively from June 1, 2021 through June 30, 2022 |
$ | |||
Amount vested from July 1, 2022 through September 30, 2022 |
||||
Amount to be vested upon the Company’s consummation of a successful business combination or November 30, 2022 (represents five additional months of vesting) |
||||
Total vesting amount |
$ |
|||
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
September 30, 2022 |
Quoted Prices In Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
|||||||||||||
Description |
||||||||||||||||
Marketable securities held in Trust Account |
$ | $ | — | — | ||||||||||||
Liabilities: |
||||||||||||||||
Working capital loan—related party |
||||||||||||||||
Warrant liabilities—Public |
||||||||||||||||
Warrant liabilities—Private |
||||||||||||||||
$ |
$ |
$ |
$ |
|||||||||||||
December 31, 2021 |
Quoted Prices In Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
|||||||||||||
Description |
||||||||||||||||
Marketable securities held in Trust Account |
$ | $ | — | — | ||||||||||||
Liabilities: |
||||||||||||||||
Warrant liabilities—Public |
||||||||||||||||
Warrant liabilities—Private |
||||||||||||||||
$ |
$ |
$ |
$ |
|||||||||||||
At September 30, 2022 |
At December 31, 2021 |
|||||||
Share price |
$ | $ | ||||||
Strike price |
$ | $ | ||||||
Term (in years) |
||||||||
Volatility |
% | % | ||||||
Risk-free rate |
% | % | ||||||
Dividend yield |
% | % |
Private Warrants (Level 3) |
Public Warrants (Level 1) |
Warrant Liabilities |
||||||||||
Fair value as of December 31, 2021 |
$ |
$ |
$ |
|||||||||
Change in fair value |
( |
) | ( |
) | ( |
) | ||||||
Fair value as of March 31, 2022 |
||||||||||||
Change in fair value |
( |
) | ( |
) | ( |
) | ||||||
Fair value as of June 30, 2022 |
||||||||||||
Change in fair value |
( |
) | ( |
) | ( |
) | ||||||
Fair value as of September 30, 2022 |
$ |
$ |
$ |
|||||||||
At September 30, 2022 |
At June 9, 2022 |
At February 28, 2022 |
||||||||||
Term (years) |
||||||||||||
Selected Debt Yield Rate (B and BB rated bond yields) |
% | % | % | |||||||||
Stock price |
$ | $ | $ | |||||||||
Strike price |
$ | $ | $ | |||||||||
Volatility |
% | % | % | |||||||||
Risk-free rate |
% | % | % | |||||||||
Dividend yield |
% | % |